CNN reports:
Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa. The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and published Wednesday in the New England Journal of Medicine.
Lenacapavir is already approved by the US Food and Drug Administration for the treatment of HIV infection in adults, in combination with other HIV antiretroviral medicines, and it’s estimated to cost more than $40,000 in a year as a manufacturer’s list price. Separate research presented Tuesday at the AIDS Conference in Munich suggests that the production of a generic version of lenacapavir could cost under $100 per person.
Read the full article.
The post STUDY: Twice-Yearly Anti-HIV Shot Is 100% Effective appeared first on Joe.My.God..